Breo Ellipta Reviewers
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
FDA staff who participated in the review of GlaxoSmithKline/Theravance’s chronic obstructive pulmonary disease combination drug fluticasone furoate/vilanterol.